UK (PRWEB UK) 17 January 2013
A major theme set at the recent Consumer Electronics Show 2013 (CES 2013) was the change in consumer health behaviour and how the public review or regulate their health and fitness. Our newly published report ‘Mobile Health: A Revolution in Self-Care’ highlights the implications, both positive and negative, that this evolution in technology is having on the consumer healthcare industry.
CES 2013 proved that Mobile Health (mHealth) is here to stay. With over 215 exhibitors at the show demonstrating some form of health-based gadget, it is clearly important for health and fitness companies to understand the trends and consumer interest in the current revolution.
Nicholas Hall & Company’s ‘Mobile Health’ report delves deep into the new ways in which smartphones and gadgets are allowing consumers to examine and monitor their health, and assisting them in promoting more positive behaviours. In addition, it considers the wealth of research material that the data-driven revolution provides healthcare companies, and the opportunities for pharmacies and OTC organisations to take a greater role in the day-to-day relationship between consumers and their health. As the mHealth trend continues, the OTC industry will see positive implications.
The report highlights:
As the report concludes: “mHealth is in its infancy, but shows strong potential to radically change the landscape of medicine.”
Marketers, developers, OTC companies and consumers need to adapt to changing technology. Through consideration of developments already in progress and looking to future possibilities, the report investigates the opportunities that mobile health offers to the healthcare industry.
About Nicholas Hall & Company
Since 1978 Nicholas Hall & Company has offered comprehensive OTC marketing and business solutions. Specialising in OTC, our consultants and market analysts have many years of experience while our international network of contacts means we can offer strategic advice, data & analysis and competitive intelligence on a global scale.
Our reports draw on the in-house expertise of our specialist analysts and researchers, on the-ground knowledge from our Network Partners, and Nicholas Hall’s unique insights, plus the latest sales data from our DB6 global OTC database. Each title provides in-depth analysis, identifies major trends and developments, highlights consumer preferences and forecasts future sales.
For more information about the report, please visit: